Shares gained 1.14% to $61.74 on Wednesday as the S&P 500 rose 1.46% to 7,365.12 and the Dow added 1.24% to 49,910.59.
Despite the advance, the stock underperformed the broader market in a broadly positive session for US equities.
GE HealthCare closed 31.23% below its 52-week high of $89.77 reached on 8 January, while trading volume of 5.4 million topped its 50-day average of 4.4 million.
Analysts see massive upside, but GEHC just cut its profit forecast. Is this a temporary stumble or a sign of deeper trouble?
Can GE HealthCare's AI innovations and record backlog overcome the crippling effects of inflation and supply chain woes?